-
1
المؤلفون: Joris Dutré, Evelien Humblet, S Vieujan, Fazia Mana, O. Dewit, N Schoofs, A Cremer, F Baert, S Delen, J F Rahier, F D'Heygere, Philip Caenepeel, S De Coninck, Sophie Dewit, A El Nawar, Clara Thienpont, Annelies Verreth, S Vanden Branden, J L Coenegrachts, Denis Franchimont, P Bossuyt, P Van Hootegem, Michaël Somers, A Vijverman, E Macken, Triana Lobaton, D Staessen, Barbara Willandt
المصدر: Journal of Crohn's and Colitis. 14:S384-S386
مصطلحات موضوعية: medicine.medical_specialty, Tofacitinib, Intention-to-treat analysis, business.industry, Surrogate endpoint, Gastroenterology, General Medicine, medicine.disease, Ulcerative colitis, Vedolizumab, Refractory, Internal medicine, medicine, Adverse effect, business, medicine.drug, Cohort study
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3e27ec77e28feaed34efc063217eace3
https://doi.org/10.1093/ecco-jcc/jjz203.551